The Motley Fool··Jonathan PoncianoBoone Capital Exits 372% Biotech Winner to Chase Emerging Clinical Plays
Boone Capital liquidates entire $13.57M Cogent Biosciences stake despite 372% gain, reallocating to earlier-stage biotech plays like TYRA. Strategic rebalancing in volatile sector.
MDTTYRAIONSCOGTBMRN+2biotechclinical-stage